Clara Lehmann
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Virology 36
- HIV Research and Treatment 36
-
- HIV/AIDS Research and Interventions 26
- HIV/AIDS drug development and treatment 21
- SARS-CoV-2 and COVID-19 Research 20
- SARS-CoV-2 detection and testing 12
- COVID-19 Clinical Research Studies 9
- Co-authors
- Norma JungGerd FätkenheuerDirk TaubertFlorian KleinEdgar SchömigRenate RoesenJan van LunzenPia Hartmann
- Journals
- Infection (20 papers)Viruses (6 papers)HIV Medicine (6 papers)Clinical Infectious Diseases (4 papers)AIDS Research and Human Retroviruses (4 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Clara Lehmann
115 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Virology 1.0k
- Infectious Diseases 1.4k
- Immunology 789
- Biochemistry 179
- Emergency Medicine 226
Countries citing papers authored by Clara Lehmann
This map shows the geographic impact of Clara Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Lehmann more than expected).
Fields of papers citing papers by Clara Lehmann
This network shows the impact of papers produced by Clara Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Lehmann. The network helps show where Clara Lehmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Clara Lehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 4 | |
| 7 | mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant Hit paper breakdown → | 2022 | 243 |
| 8 | 2021 | 6 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 9 | |
| 13 | 2018 | 3 | |
| 14 | 2018 | 5 | |
| 15 | 2016 | 13 | |
| 16 | 2015 | 13 | |
| 17 | 2013 | 59 | |
| 18 | 2013 | 15 | |
| 19 | 2009 | 29 | |
| 20 | 2007 | 350 |
About Clara Lehmann
Clara Lehmann is a scholar working on Virology, Infectious Diseases, Applied Microbiology and Biotechnology, Epidemiology and Immunology, having authored 122 papers that have together received 3.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (36 papers), HIV/AIDS Research and Interventions (26 papers), HIV/AIDS drug development and treatment (21 papers), SARS-CoV-2 and COVID-19 Research (20 papers), Immune Cell Function and Interaction (14 papers), SARS-CoV-2 detection and testing (12 papers), Long-Term Effects of COVID-19 (9 papers) and COVID-19 Clinical Research Studies (9 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (1.4k citations), Immunology (789 citations), Biochemistry (179 citations) and Emergency Medicine (226 citations). Clara Lehmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Norma Jung, Gerd Fätkenheuer, Dirk Taubert, Florian Klein, Edgar Schömig, Renate Roesen, Jan van Lunzen, Pia Hartmann, Julia Fischer and Henning Gruell. Their work appears in journals such as Infection, Viruses, HIV Medicine, Clinical Infectious Diseases and AIDS Research and Human Retroviruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.